The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan's PPV vaccination program

Tsai Ying-Huang; Hsieh Meng-Jer; Chang Chee-Jen; Wen Yu-Wen; Hu Han-Chung; Chao Yen-Nan; Huang Yhu-Chering; Yang Cheng-Ta; Huang Chung-Chi

首页> 外文期刊>Vaccine >The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan's PPV vaccination program

【24h】

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan's PPV vaccination program

机译：23价肺炎球菌多糖疫苗对75岁以上的老年人有效-台湾的PPV疫苗接种计划

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Pneumococcal infection is a serious cause of mortality and morbidity in the elderly. A nationwide pneumococcal polysaccharide vaccine (PPV) program for elderly adults aged 75 years and older was conducted in Taiwan in 2008. The efficacy of the PPV in this very elderly population was evaluated.

机译：背景：肺炎球菌感染是老年人死亡和发病的严重原因。台湾于2008年在全国开展了针对75岁以上老年人的肺炎球菌多糖疫苗（PPV）计划。评估了PPV在这一非常老年人口中的功效。

著录项

来源
《Vaccine》 |2015年第25期|共6页
作者
Tsai Ying-Huang; Hsieh Meng-Jer; Chang Chee-Jen; Wen Yu-Wen; Hu Han-Chung; Chao Yen-Nan; Huang Yhu-Chering; Yang Cheng-Ta; Huang Chung-Chi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Pneumococcal polysaccharide vaccine; Invasive pneumococcal disease; Pneumonia; Influenza vaccine; Mortality;

机译：肺炎球菌多糖疫苗;侵袭性肺炎球菌病;肺炎;流感疫苗;死亡率;

相似文献

外文文献
中文文献
专利

1. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan's PPV vaccination program [J] . Tsai Ying-Huang, Hsieh Meng-Jer, Chang Chee-Jen, Vaccine . 2015,第25期

机译：23价肺炎球菌多糖疫苗对75岁以上的老年人有效-台湾的PPV疫苗接种计划
2. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy [J] . Lu Ching-Lan, Chang Sui-Yuan, Chuang Yu-Chung, Vaccine . 2014,第9期

机译：在联合抗逆转录病毒疗法时代已接受23价肺炎球菌多糖疫苗的初次疫苗接种的HIV感染成年患者中，对7价肺炎球菌共轭疫苗的重新接种引起的血清学反应优于23价肺炎球菌多糖疫苗。
3. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older [J] . Jackson Lisa A., Gurtman Alejandra, van Cleeff Martin, Vaccine . 2013,第35期

机译：初次接种13价肺炎球菌结合疫苗或23价肺炎球菌多糖疫苗对50岁及以上成年人接种肺炎球菌疫苗后抗肺炎球菌反应的影响
4. Decision-Tree Model for Support of Health Policy Choices Based on Pneumococcal Conjugate Vaccine (PCV) Program Outcomes [C] . Andre Cohen, Casimir A. Kulikowski, Timothy Elbert, MEDINFO . 2017

机译：基于肺炎球菌共轭疫苗（PCV）计划结果的卫生政策选择支持决策树模型
5. Response to Pneumococcal-Polysaccharide Vaccine PPV23 in HIV-Positive Individuals [D] . Iyer, Anita Sridhar. 2015

机译：HIV阳性人群对肺炎球菌多糖疫苗PPV23的反应
6. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years [O] . Carla L. Black, Walter W. Williams, Rob Warnock, 2017

机译：在65岁以上的成年人中针对常规使用13价肺炎球菌结合疫苗和23价肺炎球菌多糖疫苗的免疫措施建议委员会之后在医疗保险受益人中进行了肺炎球菌疫苗接种
7. PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UK [O] . Jiang Y., Gauthier A., Keeping S.T., 2012

机译：PIN19英国的23价肺炎球菌多糖疫苗（PPV23）与13价肺炎球菌共轭疫苗（PCV13）接种老年人和高危人群的预算影响（BI）分析

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old-Taiwan's PPV vaccination program

摘要

著录项

相似文献

相关主题

期刊订阅